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1. INTRODUCTION
1.1 Aspergillus species
Aspergillus is a genus of around 200 molds found throughout much of nature
worldwide. Aspergillus was first catalogued in 1729 by the Italian priest and biologist
pier Antonio micheli. Viewing the fungi under microscope, Micheli was reminded of
the shape of an aspergillum (holy water sprinkler) and named the genus accordingly
(Taylor R. T. Dagenais et al 2009).
Aspergillus species are highly aerobic and are found in almost all oxygen-rich
environments, where they commonly grow as molds on the surface of a substrate, as a
result  of  the high oxygen tension. “In recent studies,  increased levels of Reactive
oxygen Species (ROS) were shown to be correlated with increased levels of aflatoxins
biosynthesis in  Aspergillus parasiticus (Robert  B Kammer et  al  1974).  Commonly
fungi grow on carbon- rich substrates such as monosaccharides (such as glucose) and
polysaccharides (such as amylase).  Aspergillus species are common contaminants of
starchy foods (such as bread and potatoes), and grow in or many plants and trees.
In  addition  to  growth  on  carbon  sources,  many  species  of  Aspergillus
demonstrate  oligotrophy  where  they  are  capable  of  growing  in  nutrient-depleted
environments, or environments in which there is  a complete lack of key nutrients.
Aspergillus niger is a prime example of this; it can be found growing on damp walls,
as a major component of mildew. Species of Aspergillus are important medically and
commercially.  Some species  found in  animals  have been  studied  for  years.  Some
species found in animals have been described as new and specific to the investigated
disease and others have been known as names already in use for organisms such as
saprophytes. More than 60 names of species of  Aspergillus are encountered in the
literature of pathology. For humans cases a whole range of infections such as infection
to  the  external  ear,  skin  lesions  and  ulcers  classed  as  mycetomas.  Out  of  the
approximately 200 species of Aspergillus there are about 16 which can cause infection
in humans. These include:
• Aspergillus clavatus 
• Aspergillus flavus
• Aspergillus fumigatus
• Aspergillus glaucus
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• Aspergillus nidulans
• Aspergillus niger
• Aspergillus oryzae
• Aspergillus terreus
• Aspergillus ustus
• Aspergillus versicolor
Aspergillus Symptoms
Aspergillus spores  are  everywhere  and  although  we  constantly  breathe
aspergillus spores in, it is usually not in high enough quantities to affect our health.
However if a person is breathing in a much higher amount of Aspergillus spores than
normal, as can happen if  Aspergillus is growing in a person’s home, then they can
suffer negative health symptoms. If Aspergillus exposure increases beyond a person’s
natural tolerance levels there are three main types of health effects they can suffer:
• Allergic symptoms: People who are allergic to  Aspergillus spores will suffer
allergic  reactions  if  they are  exposed  to  high  enough levels  of  Aspergillus
spores.  People with severe asthma often are sensitive to Aspergillus and can
suffer asthma attacks from exposure to Aspergillus spores.
• Toxic  symptoms:These  are caused by the mycotoxins  (such  as  aflatoxin,  a
very potent carcinogen) produced by some species of  Aspergillus,especially
Aspergillus flavus.
• Infection:  Aspergillus species can infect humans (also animals) and begin to
grow inside them, especially in the lungs. Usually only people with weakened
immune systems will be susceptible to infection by Aspergillus infections are
categorized  in  the  group  of  diseases  called  Aspergillosis,(Walsh,  TJ  et
al.2008).
Aspergillus Mycotoxins
Some species of Aspergillus molds can produce mycotoxins. These Aspergillus
species do not constantly produce mycotoxins but can be triggered to by factors such
as stress. These mycotoxins are mostly produced by the species  Aspergillus flavus.
The mycotoxins most produced by these Aspergillus molds are aflatoxins.
  As  well  as  being  very  toxic,aflatoxins  are  highly  carcinogenic  (cancer
causing) especially in animals and they have also resulted in miscarriage in animals
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such  as  sheep  and  cows.  Crops  and  foods  such  as  peanuts  and  maize  are  often
contaminated by  Aspergillus leading to mycotoxins being present.  There are safety
limits set for the amount of aflatoxins allowed in food. However there are no similar
levels set for aflatoxin concentration in the air of buildings and there has not been
enough. 
 Types of aspergillosis
The group of diseases in humans which are caused by Aspergillus exposure is
known  as  Aspergillosis  (Rosa   C et   al.,  2011,1467-71.).  The  main  diseases  of
Aspergillosis are: 
• Allergic broncho pulmonary aspergillosis
• Acute invasive aspergillosis
 Allergic Bronchopulmonary Aspergillosis
Allergic  bronchopulmonary  aspergillosis  (ABPA)  is  a  diseases  where  a
person’s immune system is hypersensitive to Aspergillus spores. This hypersensitivity
causes allergic reaction in the person when they are exposed  to Aspergillus as the
immune system tries to expel the spores from the body. People with cystic fibrosis or
asthma  are  especially  vulnerable  to  Allergic  bronchpulmonary  aspergillosis,  with
approximately 5% of asthmatics  suffering this  disease at  some point  in  their  life.
Allergic bronchpulmonary aspergillosis is usually caused by  Aspergillus fumigatus.
Symptoms:
• Difficulty breathing, shortness of breath and breathlessness
• Wheezing
• Symptoms of asthma
• Coughing up mucus
• Coughing blood
• Sinusitis(infection or inflammation of the sinuses)
• Loss of appetite
• Fever
• General malaise and feeling unwell
• In later stages can cause lung damage(fibrosis)
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Tests for allergic bronchopulmonary aspergillosis can be performed through x-
rays,  skin  tests  or  blood  tests.  The  treatment  for  allergic  bronchopulmonary
aspergillosis is for steroids to be taken through mouth or nasal spray. An antifungal
drug called itraconazole can also help to treat the disease in conjunction with steroids.
 Chronic Pulmonary Aspergillosis and Aspergillomas 
This  disease  is  caused  by  Aspergillus infecting  the  body  and  growing  in
cavities in the lungs. These cavities in the lungs would usually have to be created by a
previous health problem such as tuberculosis. Once the Aspergillus mold has infected
the lungs it begins to grow into a fungal ball (called an aspergilloma or mycetoma)
which then makes the person sick because of the allergens or toxins it puts out into the
person’s body. At first the symptoms of an aspergilloma might not be noticeable but as
time goes on it can show in health problems such as:
• Breathing problems
• Chronic coughing
• Coughing up blood
• Losing weight
• Tiredness
• Fatigue
1.2 Aspergillus  niger
Aspergillus  niger is  a  fungus and one of  the most common species  of  the
genus  Aspergillus.  It  causes  a  disease  called  black  mold  on  certain  fruits  and
vegetables such as grapes, onions. Peanuts are a common contaminant of food. It is
black colonies can be confused with those of stachybotrys (species of which have also
been called “black mold”). Some strains of Aspergillus niger have been reported to
produce potent mycotoxins called ochratoxins, but other sources disagree,claiming the
later report is based upon misidentification of the fungal species. Genomic sequences
comparisons  have  also  led  to  the  demonstration  of  another  Fumonisins  another
important mycotomicin. Recent evidence suggests some true Aspergillus niger strains
do produce ochratoxin A (Abarca  M et  al  1994).  Aspergillus  niger  is  included  in
Aspergillus subgenus circumdati, section nigri. The section nigri includes 15 related
black  spored  species  that  may  be  confused  with  Aspergillus  niger,  including
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Aspergillus tubingensis, Aspergillus foetidus Aspergillus carbonarins and Aspergillus
awamori.
Figure 1:  Aspergillus niger grown on Sabouraud agar medium.
100 x magnification
A number  of  morphologically  similar  species  were  recently  described  by
Samson et al 2001.  Aspergillus niger causes black mold of onions. Infection of onion
seedlings  by  Aspergillus  niger can  become  systemic,  manifesting  only  when
conditions are conductive. Aspergillus niger causes a common post harvest disease of
onions, in which the black conidia can be observed between the scales of the bulb.
The fungus also causes disease in peanuts and in grapes.  Aspergillus niger is  less
likely  to  cause  human  disease  than  some  other  Aspergillus species,  but  if  large
amounts  of  spores  are  inhaled,  a  serious  lung  disease,  aspergillosis  can  occur.
Aspergillosis  is  particularly frequent  among horticultural  workers  who inhale peat
dust, which can be rich in Aspergillus spores. Less commonly, it has been found on
the walls of ancient Egyptian tombs and can be inhaled when the area is disturbed.
Aspergillus  niger is  one  of  the  most  common  causes  of  otomycosis  (fungal  ear
infections), which can cause pain, temporary hearing loss and in severe cases, damage
to the ear canal and tympanic membrane. The black aspergilli are some of the most
important mycotoxigenic food and feed contaminants, especially in postharvest decay
of fresh and dried fruits and certain vegetables, nuts, beans, and cereals. This is due to
their fast growth, pH tolerance, and high abudance in many environments. For the
analytical  chemist,  issues such as  fungal  taxonomy and correct  identification may
seem of low relevance, but in fact biosystematics is a vital part of mycotoxin research
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and food safety. Since the profile of mycotoxins and other secondary metabolites is
species  specific,  correct  identification  at  the  species  level  provides  the  key  for
planning  the  analytical  determination  of  all  relevant  compounds.  The Aspergillus
niger group  (the  black  Aspergilli,  Aspergillus subgenus  Circumdati  section  Nigri)
comprises 18 species, of which  A. niger, A.tubingensis, A.brasiliensis, A. acidus, A.
carbonarius, and A.ibericus are common, whereas the remaining species are rare and
found mainly in tropical regions. A clarification of Aspergillus section nigri using the
B-tubulin and calmodulin geners showed that three clades could be distinguished. The
A. niger clade,  a clade consisting of the two rare species  A. homomorphus  and A.
ellipticus, and the clade of uniseriate black Aspergilli  (A.aculeatinus. A. aculeatus,
A.japonicus,  and A.uvarum),  the  members  of  which  differ  significantly  from  the
remaining black aspergilli  regarding their morphology,  physiological  behavior,  and
secondary  metabolite  production  (e.g.,  producers  of  neoxaline,  asperparalines,
secalonic acids, asperamide, and aculeasins). The identity and metabolite production
of  the  uniseriate  black aspergilli is  usually  not  confused  with  the  identity  and
metabolite production of A.niger and other biseriate black Aspergilli. 
A.niger  and  A.tubingensis are  probably  the  most  common  of  the  black
Aspergilli (Samson RA, et al 2001).  Secondary metabolites from these Aspergilli, the
producing organism has been identified as a black Aspergillus and then in many cases
incorrectly  named A.niger. A wrong identification  may be  further  complicated  by
insufficient molecular identification based on sequencing of ribosomal DNA with low
resolution.  Apolyphasis  approach  where  many  different  types  of  characters
(microscopy, metabolite profiling, molecular methods) are used is recommended for
the identification of  these  aspergilli Certain molecular  methods have proven quite
successful,  including  restriction  fragment  length  polymorphism  and  B-tubulin  or
calmodulin sequencing. Unit recently, the main mycotoxin from the black  aspergilli
was  considered  to  be  ochratoxin  A (OTA),  produced  in  variable  amounts  within
certain species of the group. A. carbonarius  consistently produces large amounts of
OTA, whereas only 6-10% of members of the A.niger group produce OTA and in 10-
1000 lower amounts. The third species producing OtA in section Nigri is A. sclerotio
niger, but this species has only been found once in coffee. However,  A.niger clearly
has the widest distribution and has been reported to grow and damage a much larger
number  of  crops  and  foods  worldwide,  including  corn,  peanuts,  raisins,  onions,
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mango, apples, and dried meat products. This combined with the recent discovery that
A. niger can also produce fumonisin B2 (FB2) and fumonisin B4 (FB4) necessitates
the addition of fumonisins in a number of food and feed screening programs. A.niger
exhibits  a  remarkably  versatile  metabolism,  which  has  made  it  one  of  the  most
important production organisms used for industrial fermentations. Since 1923, A.niger
has been exploited commercially for its production of citric acid, mostly for use in
food, cosmetics, and pharmaceutical preparations. In addition, the fungus has been a
rich source of industrial enzymes such as a-amylases, cellulases, and pectinases for
use  in  the  food  industries  since  the  1960. A.niger possesses  posttranslational
mechanisms capable of correctly processing proteins that are difficult to express in
traditional  host  organisms.  As  a  result,  it  is  widely  used  as  a  cell  factory  for
heterologous expression of proteins. A.niger has been considered to be nontoxic under
industrial  conditions,  and thus  to  be considered a safe production organism.  As a
result,  quite  a  number  of  A.nigr fermentations  have  been  granted  the  generally
regarded as safe (GRAS) status by the US Food and Drug Administration. However,
the potential presence of both OTA and fumonisins in A. niger emphasizes the need to
adjust  and/or  reconsider  the  screening  prodcedures  for  simultaneous  targeting  of
multiple  classes  of  mycotoxins.  Important  secondary  metabolites  produced  by
members of the A.niger group relevant to the food, feed, and biotechnology industries
were  also  studied.  Critically  scrutinizing  the  existing  literature  for  reports  of
secondary metabolites claimed to be produced by A.niger, however often just found in
a single strain or on a single occasion. Analytical results from 25 years of metabolite
profiling at  the  Center  for  Microbial  Biotechnology of  the  black  Aspergilli  (were
presented already) . The strains investigated come from a large in-house collection
(IBT Collection) and other fungal collections. 
Industrial uses
A.niger is cultured for the industrial production of many substances. Various
strains  of A.niger are  used  in  the  industrial  preparation of  citric  acid  (E330)  and
gluconic acid (E574) and have been assessed as acceptable for daily intake by the
World Health Organisation,  (Laboni Majumder et al 2010). A.niger fermentation is
generally  recognized  as  safe”  (GRAS)  by  the  United  States  Food  and  Drug
Administration  under  the  Federal  Food,  Drug,  and  Cosmetic  Act.  Many  useful
enzymes are produced using industrial fermentation of A.niger. For example, A niger
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glucoamylase is ued in the production of high fructose corn syrup, and pectinases are
used in cider and wine clarification. Alpha-galactosidase, an enzyme that breaks down
certain complex sugars, is a component of Beano and other products that decrease
flatulence.  Another   use  of  A.niger within  the  biotechnology  industry  is  in  the
production of magnetic isotope-containing variants of biological macromolecules of
NMR analysis. 
Other Uses
A.niger is  the  main  agent  in  the  fermentation  of  Pu-erhtea,  the  Okinawan
awamori spirit, and some varieties of shochu. It was reported that a secreted RNase
( J.  Holzmann  and  P.  Frank,et  al  2008) produced  by  A.niger called  actibind  has
antiangiogenic and anticarcinogenic characteristics. A.niger is  also cultured for the
extraction  of  the  enzymes  glucose  oxidase  (GO)  and  Alpha-galactosidase  (AGS).
Glucose oxidase is used in the design of glucose biosensors, due to its high affinity for
B-D-glucose. Alpha-galactosidase can be produced by A.niger fermentation; it is used
to hydrolyze alpha 1-6 bonds found in melibiose, raffinose, and stachyose. 
1.3 Mycotoxins
Mycotoxins  are  toxic,  secondary  metabolites  of  low  molecular  weight
produced by naturally occurring fungi, they are capable of causing disease and death
in humans and other animals (Chu 1992) . Because of their pharmacological activity,
some mycotoxins or mycoztoxin derivatives have found use as antibiotics,  growth
promotants, and other kinds of drugs.
The  term mycotoxin  was  coined  in  1962 in  the  after  math  of  an  unusual
veterinary crisis near London, England, during which approximately 100,000 turkey
poults died (Bennett JW and Klch M   2003 16(3):497-516) . When this mysterious
turkey  X  disease  was  linked  to  a  peanut  (groundnut)  meal  contaminated  with
secondary metabolites from  Aspergillus flavus (aflatoxins), it sensitized scientists to
the  possibility  that  other  occult  mold  metabolites  might  be  deadly.  Soon,  the
mycotoxin  rubric  was  extended  to  include  a  number  of  previously known fungal
toxins (e.g., the ergot alkaloids), some compounds that had originally been isolated as
antibiotics  (e.g.,  patulin),  and a number of new secondary metabolites revealed in
screens targeted at mycotoxin discovery (e.g., ochratoxin A).
8
Toxins  are  especially  produced  under  certain  conditions  including  the
following :
• Host  plant  stress  in  the  field:  poor  soil  fertility,  insect  damage,  high/low
temperature or moisture.
• Harvesting: late harvesting, dry crops,  slow storage filling eg silage clamp,
soil contamination.
• Storage:  wet  grain,  poor  silage  packing,  incorrect  fermentation  of  ensiled
products.               
• Finished feeds and forages: poor hygiene, exposure to air/moisture, incorrect
storage (temperature/moisture). 
Most  fungi  are aerobic (use  oxygen)  and  are  found  almost  everywhere  in
extremely  small  quantities  due  to  the  minute  size  of  their spores.  They
consume organic matter  wherever humidity and  temperature are  sufficient.  Where
conditions  are  right,  fungi proliferate into colonies and  mycotoxin  levels  become
high.  The  reason  for  the  production  of  mycotoxins  is  not  yet  known;  they  are
necessary for neither growth nor the development of the fungi. Because mycotoxins
weaken  the  receiving  host,  the  fungus  may use  them as  a  strategy  to  better  the
environment for further fungal proliferation. The production of toxins depends on the
surrounding intrinsic and extrinsic environments and the toxins vary greatly in their
severity, depending on the organism infected and its susceptibility, metabolism, and
defense mechanisms. Some of the health effects found in animals and humans include
death, identifiable diseases or health problems, weakened immune systems without
specificity to a toxin, and as allergens or irritants. Some mycotoxins are harmful to
other  micro-organisms  such  as  other  fungi  or  even  bacteria; penicillin is  one
example.It has been suggested that mycotoxins in stored animal feed are the cause of
apparent sex change in hens ( Global mycotoxin information Resource).
Mycotoxins  can  appear  in  the  food  chain  as  a  result  of fungal
infection of crops,  either  by  being  eaten  directly  by  humans  or  by  being  used  as
livestock  feed.  Mycotoxins  greatly resist  decomposition or  being broken  down in
digestion,  so  they  remain  in  the  food  chain  in  meat  and  dairy  products.  Even
temperature  treatments,  such  as  cooking  and  freezing,  do  not  destroy  some
mycotoxins. Although various wild mushrooms contain an assortment of poisons that
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are definitely fungal metabolites   causing noteworthy health problems for humans,
they are rather arbitrarily excluded from discussions of mycotoxicology. In such cases
the  distinction  is  based  on  the  size  of  the  producing  fungus  and  human
intention. Mycotoxin exposure is almost always accidental whereas with mushrooms
improper identification and ingestion causing mushroom poisoning is commonly the
case.  Ingestion of misidentified mushrooms containi  classification schemes tend to
reflect the training of the person doing the categorizing. Clinicians often arrange them
by  the  organ  they  affect.  Thus,  mycotoxins  can  be  classified  as  hepatotoxins,
nephrotoxins, neurotoxins, immunotoxins, and so forth. Cell biologists put them into
generic  groups  such  as  teratogens,  mutagens,  carcinogens,  and  allergens.  Organic
chemists have attempted to classify them by their chemical structures (e.g.,lactones,
coumarins); biochemists according to their biosynthetic origins  (polyketides, amino
acid-derived,  etc.);  physicians  by the illnesses  they cause (e.g.,  St.  Anthony's  fire,
stachybotryotoxicosis).  And  mycologists  by  the  fungi  speacies  that  produce
theme.g., Aspergillus toxins, Penicillium toxins).  The  mycotoxins  may  result  in
hallucinations.
Table 1:  Some mycotoxins, their sources and potential toxicities
Toxins Producing fungi Toxicities
Aflatoxin Aspergillus flavus Hepatocarcinogen
Ochratoxins Aspergillus ochraceus Hepatotoxin
Patulin Penicilliumc expansum Brain &lung hemorrhage
Sterigmatocystin Aspergillus flavus Hepatocarcinogen
Vomitoxin
(Deoxynivalenol)
Fusarium graminearum Vomiting
Rubratoxin Penicillium rubrum Liver  hemmorrhage  and  fatty
infiltration
Rugulosin Penicillium islandicum Nephrosis & liver damage
Mycotoxicoses  are  the  animal  diseases  caused  by  mycotoxins;
mycotoxicology is  the  study of  mycotoxins  .  While  all  mycotoxins  are  of  fungal
origin, not all toxic compounds produced by fungi are called mycotoxins. The target
and the concentration of the metabolite are both important. Fungal products that are
mainly toxic to  bacteria  (such  as  penicillin)  are  usually called antibiotics.  Fungal
products that  are toxic to plants are called phytotoxins.  The distinction between a
mycotoxin and a mushroom poison is based not only on the size of the producing
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fungus, but also on human intention. Mycotoxin exposure is almost always accidental.
In contrast, with the exception of the victims of a few mycologically accomplished
murderers,  mushroom poisons are usually ingested by amateur  mushroom hunters
who have collected, cooked, and eaten what was misidentified as a delectable species
(J.W.Bennett and M.Klch 2003).
Mycotoxicosis is  the term used for poisoning associated with exposures  to
mycotoxins. The symptoms of a mycotoxicosis depend on the type of mycotoxin; the
concentration and length of exposure; as well as age, health, and sex of the exposed
individual. The  synergistic  effects  associated  with  several  other  factors  such  as
genetics, diet, and interactions with other toxins have been poorly studied. Therefore
it is possible that vitamin deficiency, caloric deprivation, alcohol abuse, and infectious
disease status can all have compounded effects with mycotoxins.In turn, mycotoxins
have  the  potential  for  both  acute  and  chronic  health  effects  via  ingestion,  skin
contact, and  inhalation.  These  toxins  can  enter  the  blood  stream  and  lymphatic
system, they inhibit  protein synthesis,  damage macrophage systems, inhibit  particle
clearance of the lung, and increase sensitivity to bacterial endotoxin.
In 2004 in Kenya, 125 people died and nearly 200 others were treated after
eating aflatoxin-contaminated  maize. The  deaths  were  mainly  associated  with
homegrown maize that had not been treated with fungicides or properly dried before
storage. Due to food shortages at the time, farmers may have been harvesting maize
earlier than normal to prevent thefts from their fields, so that the grain had not fully
matured and was more susceptible to infection. 
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 STRATEGIES FOR PREVENTION AND CONTROL OF MYCOTOXINS  
In general, prevention of the contamination of fungi and their mycotoxins in
agricultural commodities can be divided into these following three levels.
 Primary prevention
The  step  of  prevention  should  be  initially  carried  out  before  the  fungal
infestation  and  mycotoxin  contamination.  This  level  of  prevention  is  the  most
important and effective plan for reducing fungal growth and mycotoxin production.
Several practices have been recommended to keep the conditions unfavorable for any
fungal growth. These include:
• development of fungal resistant varieties of growing plants;
• control field infection by fungi of planting crops;
• making schedule for suitable pre-harvest, harvest and post-harvest;
• lowering moisture  content  of  plant  seeds,  after  post  harvesting and during
storage;
• Store commodities at low temperature whenever possible;
• using fungicides and preservatives against fungal growth;
• control insect infestation in stored bulk grains with approved insecticides.
 Secondary prevention
If  the invasion of some fungi begins in commodities at  early phase,  at  this
level  prevention  will  then  be  required.  The  existing  toxigenic-fungi  should  be
eliminated or its growth to be stopped to prevent further deterioration and mycotoxin
contamination. Several measures are suggested as follows:
• Stop growth of infested fungi by re-drying the products;
• Removal of contaminated seeds;
• Inactivation or detoxification of mycotoxins contaminated;
• Protect stored products from any conditions which favour continuing fungal
growth.
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 Tertiary prevention
Once  the  products  are  heavily  infested  by  toxic  fungi,  the  primary  and
secondary  preventions  would  not  be  then  feasible.  Any  action  would  not  be  as
effective as the practices mentioned above, since it will be quite late to completely
stop toxic fungi and reduce their toxin formation. However, some measures should be
done  to  prevent  the  transfer  of  fungi  and  their  health  hazardous  toxins  highly
contaminated in products into our daily foods and environment. For example, peanut
oil  extracted  from poor-graded  peanut  seeds  always  contains  very  high  levels  of
aflatoxins  and  the  oil-soluble  toxin  has  to  be  eliminated  by  absorption  and
alkalinization during oilrefining process. Only a few practices are recommended:
• Complete destruction of the contaminated products;
• Detoxification or destruction of mycotoxins to the minimal level.
Since aflatoxin is the most well-known mycotoxin ever throughly studied and
its prevention and control has been most successfully practiced in various countries,
therefore, this paper will focus on such practices in certain detail for the prevention
and  control  of  aflatoxins  mycotoxin  contamination.  Successful  development  will
bring a great impact for the increased production of crops and safe and nutritious
foods around the world.  A number of researchers have been working on  A.flavus-
resistant or tolerant varieties of corn  and peanut. It  has been clear that the fungal-
resistance of  each variety is  genotypic.  However,  the resistance to  invasion of  A.
flavus has been attributed to several biochemicals, environmental and physical factors.
Uncontrollable factors could bring the failure in the utilization of selected fungal-
resistant variety, as shown by laboratory screening, in the field.
Davis and his co-workers  reported the survey and comparison of  aflatoxin
contamination in up to 215 corn hybrids grown in Alabama, USA during 1976-81.
Unfortunately, they could not find any hybrid tested resistant to aflatoxin formation.
They were convinced that  significant aflatoxin levels generally accompanied stress
caused by high temperature,  low rainfall,  low moisture-holding capacity of  sandy
soils and insect infestation.
A differential pathogenic capacity of various toxigenic strains of A.flavus have
been observed . Some strains would require physical damage for their infestation and
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others would not. The association of mycotoxin production and physical damage to
grain  and  drought  during  grain  ripening  indicates  that  Aspergillus  spp.  are  weak
pathogens.  During  long  grain  storage,  the  biochemical  activity  of  grain  is  much
reduced,  while  invasion  of  storage  fungi  and  mycotoxin  contamination  would
increase. More data is needed on the biochemistry and pathogenesis of toxigenic fungi
to understand and evaluate their genotype. The germination and viability of maize
seeds could be affected by attack of  Aspergillus and  Penicillium species and their
fungal infestation have been found to be different among maize genotypes.
Similarly, genotypes of peanut and biochemical properties of its seed such as
tannin  content,  thin  pericarp,  small  amount  of  cuticular  wax  and  chemical
composition of the pericarps and embryos have been shown to inhibit fungal invasion
by A. flavus and aflatoxin formation.
Recently,  antifungal  enzymes,  chitinase  and  B-1,  3-glucanase,  found  in  a
number of plant seeds, may act as defense against pathogenic fungi, since chitin and
glucan  are  major  polymeric  components  of  many  fungal  cell  walls.  Such
polysaccharides  in  fungal  cell  wall  could  be  enzymically hydrolysed  into  smaller
products resulting the damage or killing of fungal mycelia or spores. The role of these
enzymes for genotype evaluation is now being studied. It is foreseen that seeds rich in
such antifungal  enzymes likely resist  the infestation of  fungi.  If  so,  the seeds for
breeding would be easily screened out and used a stock one.
Even there are many technical  problems in searching for the "super" plant
against  pathogenicity,  the  development  of  fungal-resistant  plant  varieties  utilizing
genetic resistance to mycotoxin contamination is still possible and encouraged.
 Fungal Growth Inhibition    
How  to  prevent  growth  and  invasion  of  pathogenic  fungi  in  agricultural
commodities is very important in preventing mycotoxin contamination. The inhibition
of fungal growth can be achieved by physical, chemical and biological treatments 
• Physical treatment. After the crops have been harvested, drying and proper
storage  and  suitable  transportation  of  the  commodities  are  of  prime
importance. Several flavourable factors contribute to the growth of fungi and
aflatoxin  production,  namely  high  moisture  content,  humid  climate,  warm
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temperature (25-40°C), insect infestation and pes damage. Many means and
measures to prevention of fungal contamination have been emphasized and
practically done.
• Drying seeds and commodities to the safe moisture levels (<9% for peanut
kernel, and < 13.5% for corn) .
• Maintenance of the container or warehouse at low temperature and humidity.
• Keep out insects and pests from the storage
• Gamma-irradiation of large-scale commodities.
• Chemical treatment with synthetic fungicides.
• Organic acids: acetic acid, propionic acid, butyric acid, malonic acid , benzoic
acid, asorbic acid, lactic acid, citric acid  and their sodium salts.
• Sodium chloride 
• Benzoic acid derivatives: Onitrobenzoate, O-aminobenzoate, paminobenzoate,
benzocain (ethly aminobenzoate), ethyl benzoate, methyl benzoate and aspirin
(O-acetoxy benzoic acid)
• Potassium sulfite and potassium fluoride
• Fumigant: ammonia and phosphine .
• Treatment with natural products from plants or herbs.
1.4 Kojic Acid
Kojic acid (KA) is a secondary metabolite produced by some species of fungi
from the genera Aspergillus, Penicillium and Acetobacter, it is produced biologically
by different types of fungi during aerobic fermentation using various substrates. The
name ‘Kojic  acid’ (which  was  originally  known  as  Koji  acid)  was  derived  from
“Koji”, the fungus starter orinoculum used in oriental food fermentations for many
centuries. Kojic acid was originaly isolated in Japan by Saito in 1907 from mycelia of
Aspergillus oryzae grown on steamed rice. This rice is called “koji” in Japanese, and
this  name  was  given  to  that  organic  compound  by  Yabuta  in  1913.  Its  chemical
structure  was  then  extensively  investigated  and  defined  as  5-hydroxy-2-
hydroxymethyl-g-pyrone (Yabuta, 1924). Chemical synonyms of kojic acid are known
as 5-hydroxy-2- hydroxymethyl-4H-pyran-4-one (Nandan and Polasa, 1985) and 5-
hydroxy-2-hydroxymethyl-4-pyrone (Kahn et al., 1995).
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The properties of kojic acid
Kojic acid crystallises in the form of colourless, prismatic needles that sublime
in vacuum without any changes. Mean while, the melting point of  kojic acid ranges
from 151°C -  154°C  (Ohyama and Mishima, 1990). Kojic acid is soluble in water,
ethanol and ethyl acetate. On the contrary, it is less soluble in ether, alcohol ether
mixture,  chloroform and pyridine (Wilson, 1971) .  The molecular  weight  of  kojic
acid, as determined by the cryoscopic method for a formula of C6H6O4, is 142.1
(Uchino  et  al.,1988)  .  Kojic  acid  has  a  maximum  peak  of  ultraviolet  absorption
spectra at 280 -284 nm  (Choi et al.,  2002; Watanabe-Akanuma et al.,  2007) .The
chemical structure of kojic acid is shown below indicates that: 
Kojic acid
Molecular formula- C6H6O4
CAS NO- 501-30-4     
Melting Point- 151-154oC,  
Molecular Weight- 142.1
Kojic acid is classified as a multifunctional, reactive g- pyrone with weakly
acidic properties. It is reactive at every position on the ring and a number of products
which  have  values  in  industrial  chemistry,  such  as  metal  chelates,  pyridones,
pyridines, ethers, azodyes, mannich base, and the products of cyanoethylation can be
formed from kojic acid (Ichimoto et al.,  1965; Wilson, 1971). Numerous chemical
reactions  of  kojic  acid have  been  studied  over  the  decades  since  its  isolation.  At
carbon 5 positions, the hydroxyl group acts as a weak acid, which is capable to form
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salts  with few metals such as  sodium, zinc,  copper,  calcium, nickel  and cadmium
(Crueger  and  Crueger,  1984).  Kojic  acid  is  produced  by  Aspergillus  spp  and
Penicillium spp., belonging mainly to the flavus-oryzaetamarii groups. Among them,
A.flavus  (Basappa et al., 1970; Ariff et al., 1996),  A.oryzae  (Kwak and Rhee, 1992;
Takamizawa et al., 1996),  A.tamarii  (Gould, 1938) and  A. parasiticus  (Nandan and
Polasa, 1985; Coupland and Niehaus, 1987; El-Aasar, 2006) were reported to have the
ability to produce large amounts of  Kojic acid. Although, several potential Kojic acid
producing  strains  have  been  isolated,  very  little  attention  has  been  paid  to  the
improvement  of  the  strains,  either  through  mutation  or  genetic  engineering
techniques.  Details  of  industrial  techniques  of  Kojic  acid  fermentation  are  rarely
revealed since they comprise the proprietary know-how of each producing company,
A.niger can produce a variety of mycotoxins including oxalic acid, kojic acid, and
cyclic pentapeptides called malformins (Kobbe et al., 1977; Wilson, 1966).
There are varieties of culture media used for production of  Kojic acid such as:
• Modified Czapek –Dox medium
• The medium of Tadera
• Yeast extract sucrose medium
Carbon sources
A variety of carbon containing substrates may be used as carbon sources for
Kojic  acid  fermentation  .These  substrates  include  starch,  sucrose,  maltose,
glucose,fructose,  mannose,  galactose,  xylose,  arabinose,  sorbitol,  acetate,  ethanol,
glycerol and arabinose (Arnstein and Bentley,  1956; Wilson, 1971; Burdock et al.,
2001; Rosfarizan and Ariffv 2007).
Nitrogen sources
There are variations in nitrogen sources chosen for Kojic acid fermentation
from  several  strains  of  Aspergillus  spp.  Kitada  et  al.  1967  reported  that  organic
nitrogen sources are generally better than inorganic nitrogen sources for Kojic acid
fermentation. Complex organic nitrogen sources such as peptone and yeast  extract
may  contain  vitamins,  which  act  as  a  precursor  for  Kojic  acid  production.
Furthermore,  some organic  nitrogen  sources  have  a  good buffering  system,  while
inorganic  nitrogen  sources,  such  as  ammonia,  excessively  reduce  the  culture  pH
during NH4+ absorption. Low pH may influence the synthesis of Kojic acid during
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fermentation and inhibit its growth. Yeast extract has been reported to be the most
favourable organic nitrogen source for kojic acid production as compared to peptone
and polypeptone  (Wei et al.,1991; Ariff et al., 1996) . However, Kitada et al. (1967)
and Coupland and Niehaus (1987) claimed that peptone is better than yeast extract for
Kojic acid production. The presence of important growth factors, such as vitamins and
oligoelements in specific nitrogen sources, also plays an important role in enhancing
Kojic acid production (Gad,  2003).  Kojic acid reversibly affects thyroid function
primarily by inhibiting iodine uptake, leading to decreases in T3 and T4 and increase in
TSH.  Increased  TSH  from  pituitary  gland  in  turn  stimulates  thyroid  hyperplasia.
Several lines of evidence indicate that the proliferative effects of kojic acid on thyroid
are not related to a genotoxic pathway.  The risk of functional inhibition of iodine
uptake and its metabolism  (organification)  and thyroid tumor induction by kojic acid
in humans appears to be extremely low.
Applications 
Whitening  of  skin,  Antimicrobial,  Antineoplastic,  Analytical  chemical,
Chelating agents, Precursor for flavor enhancers, Conjugated with chitosan and amino
acids for higher tyrosinase inhibition activity.
 This  organic  compound  (Kojic  acid)  continue  toattract  attention  because  of  its
economic  potential  in   the  field  of  ,  Medicine,  Food,  Cosmoteic  and  agricultural
products.
Food industry 
Kojic  acid  is  used  as  an  inhibitor  of  polyohenol  oxidase,  an  enzyme
responsible for the blackening of agricultural products ( prevent oxidative browning).
Medicine and Cosmetic
Kojic acid is used mainly because it can eliminate free radicals and thus act as
antioxidant. Kojic acid in the the form of gels and soaps is to achieve skin lightening
effect  by  inhibiting  the  enzyme  tyrosinase  there  by  reducing  the  production  of
melanin formation, its also blocks the formation of pigmentation and even out skin
tone, at present is introduced into various kinds of cosmoteics like  curing freckles ,
lightining age spots on the skin , acne and stretch marks due to obesity and pregnancy.
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1.5  Cytotoxic and cell proliferation assay
Cell viability and proliferation can be determined by three different methods
as described below:
a. MTT Assay   
Principle of assay:
This  is  a  colorimetric  assay that  measures  the  reduction  of  yellow 3-(4,5-
dimethythiazol-  2-yl)-2,5-diphenyl  tetrazolium  bromide  (MTT)  by  mitochondrial
succinate dehydrogenase. The MTT enters the cells and passes into the mitochondria
where it  is reduced to an insoluble, coloured (dark purple) formazan product.  The
cells are then solubilised with an organic solvent (eg. isopropanol) and the released,
solubilised formazan reagent is measured spectrophotometrically. Since reduction of
MTT can only occur in metabolically active cells the level of activity is a measure of
the viability of the cells.
b. Neutral red (NR) uptake assay
The cytotoxicity neutral red test is based on the abi0.lity of live cells to uptake
and bind neutral red (NR). 
NR is a positively charged dye that easily diffuses through the cellular membrane of
the  cells,  accumulates  in  the  cellular  cytoplasma  and  is  stored  in  the  acidic
environment of lysosomes. The principle of the test consists in the fact that NR are
able to adsorb and bind only live cells while this ability declines in damaged or dead
cells. The amount of accumulated NR is thus directly proportional to the amount of
live cells in the cell cultur. The cytotoxicity neutral red test is based on the ability of
live cells to uptake and bind neutral red (NR). NR is a positively charged dye that
easily diffuses through the cellular membrane of the cells, accumulates in the cellular
cytoplasma and is stored in the acidic environment of lysosomes. The principle of the
test consists in the fact that NR are able to adsorb and bind only live cells while this
ability declines in damaged or dead cells.  The amount of accumulated NR is thus
directly proportional to the amount of live cells in the cell culture.
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The neutral red (NR) assay procedure is a cell survival/viability It is generally
performed on adherent cells. NR is a weak cationic dye that readily penetrates the cell
membrane and accumulates intracellular in lysosomes (lysosomal pH , cytoplasmic
pH),  where it  binds  with anionic sites to  the lysosomal  matrix  (G.  Griffon,  et  al.
1995).  Changes  of  the  cell  surface  or  the  sensitive  lysosomal  membrane  lead  to
lysosomal  fragility  and  other  changes  that  gradually  become  irreversible.  Such
alterations brought about by the action of xenobiotics result in a decreased uptake and
binding of NR. It  is thus possible to distinguish between viable, damaged, or dead
cells, which is the basis of the assay. The quantity of dye incorporated into cells is
measured by spectrometry at 540 nm, and is directly proportional to the number of
cells  with an intact  membrane. The assay can be used to evaluate cytotoxicity by
determination of the IC50 (50% inhibiting concentration( . The NR assay is based on
the ability of viable cells to incorporate and bind the supravital dye NR in lysosomes,
via active transport. NR is a weak cationic dye and penetrates cell  membranes by
nonionic diffusion, subsequently binding intracellular to sites of the lysosome. Cell
membrane injuries decrease the uptake and retention of NR.
c.  Propidium iodide (PI) assay
Propidium  iodide  solution  (PI)  is  a  membrane  impermeant  dye  and  an
intercalating agent. 
When added to a cell population, PI will penetrate cells with ruptured membranes to
bind to DNA providing a strong fluorescent signal which can be readily visualised
using fluorescence imaging or  micropscopy.  As such,  it  is  a  commonly used as a
dependable marker for ‘dead cells’ in a population of ‘live cells’. Fluorescence-only
approaches to PI imaging are normally well suited for counting the ‘dead cells’ but
then require a work around to measure the live cell population. This can mean either a
separate fluorescent dye and imaging channel or commonly, taking a separate sample,
rupturing the membranes and then doing a separate PI count on this second sample.
By being forced to double up the sample clearly doubles theworkload and associated
expence but crucially looses a direct link between what is ‘dead’ and what is ‘live’ on
a  single  image  The   Cellometer  Vision  (figure  1)  uses  a  novel  brightfield  plus
fluorescent approach to PI imaging to display clearly, on a single sample, the cells
which are stained with PI and which are not. Cell counting is automated and rapid,
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taking between 30 – 60 seconds for  a  count  and  results  are  clearly displayed  on
screen.
2. LITERATURE REVIEW
            Blumenthal CZ 2004 studied on Aspergillus niger, Aspergillus oryzae , and
Trichoderma  reesei  are  three  important  production  organisms  used  in  industrial
fermentations.  Several  of  the  fungal  secondary  metabolites  produced  by  selected
strains of these three fungi are capable of eliciting toxicity in animals. Among those
toxic substances are the well-known mycotoxins 3-nitropropionic acid and ochratoxin
A.  However,  many others,  such  as  Kojic  acid,  may not  be  true  mycotoxins.  The
production, extraction, chemical structure, and the toxicity (expressed as LD(50)) of
these  substances  were  reviewed.  Production  of  toxic  secondary  metabolites  in
A.niger,  A.oryzae, and  T.  reesei  is  strain-specific  and  environment-dependent.
Considering all  of  the safety measures  taken in  the industrial  production process,
these three fungal species are safe to use. The recently revised  JECFA specification
for   mycotoxins  in  food  enzyme  preparations  was  also  discussed.  The  extent  of
mycotoxin tests  in  food enzyme preparations  should be judged  on a  case-by-case
basis, through a careful evaluation based on knowledge of taxonomy, biochemistry,
and  genetics.  In  many  cases,  the  testing  scope  at  the  level  of  genus  should  be
sufficient. In other cases, the scope can even be further narrowed based on scientific
knowledge and assessment.
D'Mello  and  Macdonald  1998  investigated  that  mycotoxins  are  those
secondary metabolites of fungi that  have the capacity to impair animal health and
productivity  (D'Mello  and  Macdonald,  1998).  The  diverse  effects  precipitated  by
these  compounds  are  conventionally  considered  under  the  generic  term
"mycotoxicosis", and include distinct syndromes as well as non-specific conditions,
also indicates the fungal species associated with the production of these contaminants.
Mycotoxin  contamination  of  forages  and  cereals  frequently  occurs  in  the  field
following  infection  of  plants  with  particular  pathogenic  fungi  or  with  symbiotic
endophytes.  Contamination  may  also  occur  during  processing  and  storage  of
harvested products and feed whenever environmental conditions are appropriate for
spoilage fungi.  Moisture content and ambient temperature are key determinants of
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fungal  colonization  and  mycotoxin  production.  It  is  conventional  to  subdivide
toxigenic  fungi  into  "field"  (or  plant-pathogenic)  and  "storage"  (or
saprophytic/spoilage) organisms. Claviceps, Neotyphodium, Fusarium and Alternaria
are  classical  representatives  of  field  fungi  while  Aspergillus  and Penicillium
exemplify storage organisms. Mycotoxigenic species may be further distinguished on
the basis of geographical prevalence, reflecting specific environmental requirements
for growth and secondary metabolism. Thus, Aspergillus flavus, A. parasiticus and A.
ochraceus  readily  proliferate  under  warm,  humid  conditions,  while  Penicillium
expansum  and  P.  verrucosum are  essentially  temperate  fungi.  Consequently,  the
Aspergillus mycotoxins predominate in plant products emanating from the tropics and
other  warm regions,  while  the  Penicillium mycotoxins  occur  widely in  temperate
foods, particularly cereal grains. Fusarium fungi are more ubiquitous, but even this
genus contains toxigenic species that are almost exclusively associated with cereals
from warm countries.
Patricia  A  and  Murphy  et  al  2006  reported  that  unavoidable,  natural
contaminants  in  foods  may have either  chemical  or  biological  origin.  Mycotoxins
toxic secondary metabolites of fungi are biological in origin. Despite efforts to control
fungal contamination, toxigenic fungi are ubiquitous in nature and occur regularly in
worldwide food supplies due to mold infestation of susceptible agricultural products,
such as cereal grains, nuts, and fruits. Thousands of mycotoxins exist, but only a few
present significant food  safety challenges. The natural fungal flora associated with
foods is dominated by three genera Aspergillus,  Fusarium,  and  Penicillium,  which
except  for  the Fusarium  plant  pathogens,  may  include  commensals  as  well  as
pathogens. The chemical  structures of mycotoxins produced by these fungi are very
diverse,as  are  the  characteristics  of  the   mycotoxicoses.  Ergotism   is  the  oldest
identified  mycotoxicosis  in humans. This mycotoxin represents a group of alkaloids
that grow on the heads of grasses, such as wheat and rye. Ergot was responsible for a
disease of the Middle Ages known as “St. Anthony’s Fire,” so named for the burning
sensation cause din victims’ limbs.The Spartans apparently suffered an ergot epidemic
in 430 B.C.. Ergotism has  also been  associated  with  the  Salemwitch trials  in  the
1600s in Massachusetts. More recent outbreaks, associated  with economic up heaval
and  war, have occurred  in Russia (1924 and 1944), Ireland (1929) ,France  (1953),
and  Ehiopia (1978). Although ergot  poisoning continues to pose achallenge for the
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live stock  industry, the toxin is  less of achallenge for  the food industry because
current  food  quality  control  procedures  screen  out  ergot-infected  grains.  Of   the
thousands of existing  mycotoxins, a few hundred are associated  with food  and only
a handful  present food safety challenges to the farm-to-fork  food continuum. At the
farmlevel, mold growth can result in reduced crop yields and livestock productivity
stemming from illness or death due to consumption of  contaminated feed. In food
manufacturing, destruction of mycotoxins by conventional food processing is difficult
because  they  are  typically  highly  resistant  and  detection  is  complicated  due  to
limitations  in  analytical  methodology.  In  the  marketplace,  mycotoxins   can   be  a
hurdle to international trade, leading  to increase d regulation of foods and feeds that
may  contain  them  and  removal  from  the  market  of  commodities   not  meeting
regulatory  limits.  when  present  in  foods  in  sufficiently  high  levels,  these  fungal
metabolites can have toxic effects that range from acute (for example, liver or kidney
deterioration), to chronic (for example, liver cancer), mutagenic, and teratogenic; and
resulting symptoms range from skin irritation to immune suppression, birth defects,
neurotoxicity,and death(ICMSF 1996). Aflatoxin B1 (AFB1), fumonisins, and  patulin
are suspected  human carcinogens.Deoxynivalenol and other trichothecenes aswell as
AFB1 are likely to exert  immunosuppressive effects,  and fumonisin B1(FB1) may
contribute to neural tube defects. Renal dysfunction due to ochratoxin  A exposure
(suspected  in  Balkan  endemic  nephropathy)  is  also  apotentially  significant
problem,especially  as  this  could exacerbate  impaired  renal  function in  individuals
with diabetes, a burgeoning worldwide epidemic that  is highly likely to grow. There
is  also uncertainty related  to  the  effects  of  chronic  low-level,  long-term exposure
tosingle  and/or  multiple  mycotoxins,  which  may  be  the  case  even  for  those
individuals  consuming  adiverse  diet.  Environmental   factors   affect  mycotoxin
presence  in  raw and  stored  commodities.  Data  on optimal  temperature  and  water
activity  for  toxin  production  by  Aspergillus,  Penicillium,  and Fusarium  spp.
Traditionally,  control  of  mycotoxin  contamination  of  foods  has  been  attempted
through control  of  water  activity,  pH and quality control  of incoming ingredients.
Novel control avenues are emerging, including availability of genetically modified
grains with increased insect resistance and, thus, lowered rates of fungal infection;
improved management of grain ingredients; and inclusion of controls for mycotoxins
in  food   manufacturing Hazard  Analysisand  Critical  Control  Point(  ACCP)  plans.
Genotyping  techniques  have  shed  new  light  on  mycotoxin  producing  fungi  and
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provided the foundation for advances in detection methodology. Historically,  fungi
have  been  identified  on  the  basis  of  traditional  taxonomic  characteristics  (for
morphological features); more  recently, the tools of molecular biology have enabled
genetic analysis and classification on on the basis of  nucleic acid sequence.Since
analytical  methods  for  detecting  mycotoxin  shave  become  more  prevalent,
sensitive,andspecific ,surveillance of foods for mycotoxin contamination has become
more common.
        Wojciech Dabrosand Anna Kordowiak 2007 proved the biochemical activity and
morphology of  control  and streptozotocin-diabetic  rat  liver  Golgi  complexes  were
previously investigated by us under influenc of some vanadium [V(IV)] compounds.
The effectiveness of these derivatives depends on the kind of complexing ligands.
This paper presents the investigation of the effect of bipyridyl, the ligand of a new
vanadium compound, tested by us with maltol and Kojic acid. The three ligands alone
action was tested under the same experimental  conditions as in the case of whole
compounds with vanadium and applied to liver Golgi complexes of control rats. A
preliminary study for maltol and Kojic acid had been previously carried out by us
parallel  with  tests  of  whole  vanadium  complexes,  but  valuable  differences  in
biological action found in our condition of experiments suggested the extension of
studies to include the two above-mentioned ligands and to compare the effects of the
three investigated ligands. The supplementary part of the experiment focused mainly
on the ultrastructure of Golgi complexes in hepatocytes. Four groups of animals were
used: C-control rats,C + M (maltol), C + (ka)2 (kojic acid) and C + (bpy)2 (bipyridyl).
The control rats received 0.09M NaCl as drinking liquid; all the other animals were
given 3.6 mmol/L of appropriate ligand solution in 0.09M NaCl during 7 days. All the
animals survived the experiments. Only in group C+(bpy)2 did the authors observe
statistically  significant  differences  as  compared  with  the  controls  (group  C).  The
differences  were detected  in  physiological  studies  and manifested  as  body weight
decreased by approximately 20% during the experiment, lower liquid.
Russell R and M Paterson 2010 assessesed the impact of climate change on
mycotoxins in food. Climate change is  an accepted probability by most scientists.
Favourable temperature and water activity are crucial for mycotoxigenic fungi and
mycotoxin production. Fungal diseases of crops provide relevant information for pre-
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harvest mycotoxin contamination. However, the mycotoxin issue also involves post-
harvest scenarios. There are no data on how mycotoxins affect competing organisms
in  crop  ecosystems.  In  general,  if  the  temperature  increases  in  cool  or  temperate
climates,  the  relevant  countries  may  become  more  liable  to  aflatoxins.  Tropical
countries may become too inhospitable for conventional fungal growth and mycotoxin
production.  Currently  cold  regions  may  become  liable  to  temperate  problems
concerning   ochratoxin.  A,  patulin  and  Fusarium  toxins  (e.g.  deoxynivalenol).
Regions which can afford to control the environment of storage facilities may be able
to avoid post-harvest problems but at high additional cost. There appears to be a lack
of  awareness  of  the  issue  in  some non-European  countries.  The  era  will  provide
numerous challenges for mycotoxicologists.
Hee Youn Chee and  Eun Hee 2003 proved  that  Kojic  acid  has  antifungal
activity  against  the  human  pathogenic  fungi  including  Candida  albicans,
Cryptococcus neoformans and Trichophyton rubrum. For C. albicans, C. neoformans
and T. rubrum, the MIC (minimum inhibitory concentration) of Kojic acid was 640,
80 and 160 mg/ml,  respectively.  In  C.neoformans,  melanin-producing yeast,  Kojic
acid treated  nonmelanized cell was more susceptible to magainin than melanized cell,
suggesting melanin give a protective function against microbial peptide.
El-Aasar  SA 2006  screened  five  local  Aspergillus species  for  Kojic  acid
production statically on four  proposed kojic  acid producing synthetic  medium. A.
parasiticus was found to be the highly active organism for acid  production. The study
implicated  the optimization of different culture conditions of fermentation medium;
initial pH, incubation temperature, carbon source concentration (glucose, sucrose &
sugar  beet  molasses),  nitrogen  source  concentration  (yeast  extract,  peptone,
ammonium sulphate, ammonium nitrate & their combinations) and changes of Kojic
acid yield in static and rotary shaking culture. The highest level of kojic acid (34.38 g
L-1) was obtained by A. parasiticus using fermentation medium of 6% glucose, 1%
yeast extract with initial pH 5 and incubated at 28°C for 10 days under rotary shaking
culture  (220  rpm).  Antimicrobial  activity  of  Kojic  acid  was  compared  to  some
antibiotics  against  three Gram – ve,  three  Gram + ve bacteria  and two strains  of
Candida.  They cocluded  that  enhanced production of  Kojic  acid  was  successfully
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achieved by optimizing the fermentation conditions for growth and productivity of A.
parasiticus.
Ana Paula D Rodrigues et al 2011 demonstrated skin whitening, antioxidant,
and antitumour properties of Kojic acid (KA) a secondary metabolite isolated from
Aspergillus fung.  The aim of their  study was to analyse whether Kojic acid (KA)
affects functional properties related to macrophage activation, such as phagocytosis
and spreading ability over a substrate.  Treatment of resident macrophages with 50
mg/ml KA for 1 h induced both morphological and physiological alterations in cells.
Immunofluorescence microscopy revealed enhanced cell spreading and an increase in
cell  surface  exposure,  associated  with  a  rearrangement  of  microtubules,  actin
filaments  and  intermediate  filaments.  KA  also  potentiated  phagocytosis  by
macrophages, as demonstrated by the increase in phagocytic activity towards yeast,
when  compared  to  untreated  cells.  Kojic  acid  increased  the  production  of  ROS
(reactive oxygen species), but not NO (nitric oxide) production. Three tests were used
to assess cell  viability;  MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl  tetrazolium
bromide], NR (neutral red) uptake and PI (propidium iodide) exclusion test, which
showed  that  macrophages  maintain  their  viability  following  Kojic  acid  treatment.
Results  indicate  that  Kojic  acid  can  modulate  macrophage  activation  through
cytoskeleton rearrangement, increase cell surface exposure, enhance the phagocytic
process and ROS production. The study demonstrates a new role for Kojic acid  as a
macrophage activator.
Rashad  M  Saleh  et  al  2011  focused  on  the  production  of  antibacterial
compound  from  Trichoderma  spp. Screening  of  antibacterial  activities  in  some
Trichoderma spp. was investigated using CYS80 medium.  Trichoderma reesei  and
Trichoderma viride were highly effective toward human-pathogenic bacteria tested. T.
viride  and T. reesei were separately applied on Sephacryl  S–200 column. Column
fractions  No.  56  to  64  for  T.viride  and  fractions  No.  57  to  66  for  T.reesei had
inhibitory effect against the most pathogenic bacteria examined. T. reesei and T. viride
Sephacryl  S-200  fractions  with  antibacterial  activity  were  analyzed  by  Gas
chromatography–mass spectrometry (GC- MS). The product with highest peak (95%),
using different libraries, was Kojic acid. The yield of Kojic acid crystals from T.reesei
and  T.viride Sephacryl  S-200  fractions  were  3  and  5  g/L,  respectively.  Physical
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analysis of Kojic acid with respect to UV, IR, 1HNMR analysis and melting point was
examined.  The  minimum  inhibitory  concentration  (MIC)  of  Kojic  acid  and
augmentin, as control, against human-pathogenic bacteria were evaluated. Kojic acid
and  augmentin  showed  a  similar  time-killing  kinetics  with  human-pathogenic
bacteria.  The level of Kojic acid increased with decreased level of reducing sugar
during the growth of T. reesei and T. viride suggesting that the enzyme system for the
synthesis of kojic acid found in the cell of these fungi.
George A Burdock et al 2000 reviwed and reported that Kojic acid is a fungal
metabolite  commonly  produced  by  many  species  of Aspergillus, Acetobacter,  and
Penicillium.  The Aspergillus  flavus group  has  tradiationally  been  used  in  the
production of a number of foods, including  miso (soybean paste), shoyu (soy sauce),
and sake.  Kojic  acid  is  widely  used  as  a  food  additive  for  preventing  enzymatic
browning,  and  in  cosmetic  preparations  as  a  skin-lightening  or  bleaching  agent.
Because Kojic  acid is  often produced during the fermentation of  historically used
dietary staples, it has a long history of consumption. Various types of compounds,
such as glucose, sucrose, acetate, ethanol, arabinose, and xylose, have been used as
carbon sources for kojic acid production. Different Aspergillus species are known to
produce variable amounts of kojic acid. The mechanism of action of Kojic acid is well
defined and it  has  been shown to act  as a  competitive and reversible inhibitor of
animal and plant polyphenol oxidases, xanthine oxidase, and L- and some L-amino
acid  oxidases.  The  structure  of  kojic  acid  indicates  a  relatively  simple  route  of
metabolism much like dietary hexoses. Acute or subchronic toxicity resulting from an
oral dose has not been reported, but convulsions may occur if Kojic acid is injected.
Results of mutagenicity studies are mixed, but in the in vivo mammalian dominant
lethal assay, Kojic acid was proven negative. Continuous administration of high doses
of Kojic acid in mice resulted in induction of thyroid adenomas in both sexes. Kojic
acid reversibly affects thyroid function primarily by inhibiting iodine uptake, leading
to decreases in T3 and T4 and increase in TSH. Increased TSH from pituitary gland in
turn  stimulates  thyroid  hyperplasia.  Several  lines  of  evidence  indicate  that  the
proliferative effects of Kojic acid on thyroid are not related to a genotoxic pathway.
The risk of  functional  inhibition of iodine uptake and its metabolism (organification)
and thyroid  tumor induction by Kojic acid in humans appears to be extremely low.
Based  on  the  literature  reviewed  and  discussed  here,  common  contaminant
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consumption  of   Kojic  acid  at  levels  normally  found in  food  does  not  present  a
concern for safety.
Jong  H.  Kim et  al  2011,  proved  that  the  natural  compounds  that  pose  no
significant medical or environmental side effects are potential sources of antifungal
agents,  either  in  their  nascent  form or  as  structural  backbones  for  more  effective
derivatives.  Kojic acid (KA) is  one such compound.  It  is  a  natural  by-product  of
fungal fermentation commonly employed by food and cosmetic industries. We show
that  Kojic  acid  greatly  lowers  minimum  inhibitory  (MIC)  or   fungicidal  (MFC)
concentrations  of  commercial  medicinal  and  agricultural  antifungal  agents,
amphotericin B (AMB) and strobilurin, respectively,  against pathogenic yeasts and
filamentous  fungi.  Assays  using  two  mitogen-activated  protein  kinase  (MAPK)
mutants, i.e., sakA∆, mpkC∆, of Aspergillus fumigatus, an agent for human invasive
aspergillosis,  with  hydrogen  peroxide  (H2O2)  or  AMB  indicate  such  chemo
sensitizing activity of Kojic acid is most conceivably through disruption of fungal
antioxidation systems. Kojic acid could be developed as a chemosensitizer to enhance
efficacy of certain conventional antifungaldrugs or fungicides.
Rosfarizan  Mohamad  et  al  2010  proved  Kojic  acid,  5-hydroxy-2-
hydroxymethyl-g-pyrone, has many potential industrial applications. In this review,
the properties and diverse applications of kojic acid in industries are described. The
review also discusses the advance in Kojic acid fermentation, focusing on the process
development  in  microorganisms  and  strain  selection,  medium  and  culture
optimization, as well as fermentation modes for commercially viable industrial scale
production.
Yu-Hua Chen et al 2013 Synthesized and examined three classes of kojic acid
derivatives for their antiproliferative activity against HeLa cells. Both 8b and 11 co-
treated with copper ion exhibited synergistic effect on the HeLa cell growth inhibition
with GI50 values of 11.9 and 7.1 µM, respectively. Flow cytometric analysis of HeLa
cells revealed that 11-Cu co-treatment induced the sub-G1 arrest in a dose-dependent
manner,  suggesting  that  the  growth-inhibitory  effect  is  attributed  to  DNA
fragmentation. Moreover, western blot of HeLa cells cytosolic extracts displayed the
cleavage  of  the  116-kDa  protein  poly(ADP-ribose)  polymerase  and  activation  of
caspase-3 by the reduced level of the 32-kDa proenzyme, indicating that the caspase-
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dependent apoptotic pathway was involved. Further they demonstrated that MAPK
pathway regulators such as  ERK and p38 were activated in response to11-Cu co-
treatment,  suggesting  that  the  intracellular  oxidative  stress  was  dramatically
stimulated by the copper  ion.  
Rosfarizan  et al 1998  made a direct conversion of gelatinized sago starch into
Kojic acid by Aspergillus flavus strain having amylolytic enzymes was carried out at
two different scales of submerged batch fermentation in a 250-mL shake flask and in a
50-L stirred-tank  fermentor.  For  comparison,  fermentations  were  also  carried  out
using glucose and glucose hydrolyzate from enzymic hydrolysis  of sago starch as
carbon sources. During Kojic acid fermentation of starch, starch was first hydrolyzed
to glucose by the action of α-amylase and glucoamylase during active growth phase.
The glucose remaining during the production phase (non-growing phase) was then
converted to Kojic acid. Kojic acid production (23.5g/L) using 100 g/L sago starch in
a  shake  flask  was  comparable  to  fermentation  of  glucose  (31.5  g/L)  and  glucose
hydrolyzate (27.9 g/L) but in the 50-L fermentor was greatly reduced due to non-
optimal aeration conditions. Kojic acid production using glucose was higher in the 50-
L fermentor than in the shake flask.
Satomi Kawagushi et al 2007 stated that  Kojic acid is used as  a cosmetic
agent for skin whitening , information for its genotoxicity in  in vitro assay is much
complicated  .in  order  to  evaluate  its  genotoxic  potentials  in  vitro  they conducted
comet assay in regular and acellular versions, chromosome aberration assay and TK
mutation assay in human lymphoblastoid cells. Positive assay were obtained in all
comet,  chromosome  aberration  and  TK  mutation  assays  at  almost  identical
concenteration in both TK6 and  WTK1 cells. In the acellular comet assay , Kojic acid
led to positive response at  pH 12 and pH 13suggested that  it  induce DNA single
strand breaks (SSBs). In the TK mutation assay Kojic acid increased the fraction of
normal  growing  but  not  slowly  growing  mutants  suggesting  that  observed  gene
mutation are due to point mutation with in TK locus but not growth structural changes
that can form chromosome aberrations observed by a microscopy. 
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3. SCOPE AND AIM
Kojic  acid  is  utilized  in  cosmaceutical  industry  for  the   purpose  of  skin
whitening agent. 
          Kojic acid is reported to have anticancer and antimicrobial property. Few
reports, demonstrate Kojic acid as toxic material. Many experiments are carried out to
understand the toxicity.
In veiw of this current study was aimed to optimize the carbon and nitrogen
sources need for the production of Kojic acid from a fungal species and to determine
the antimicrobial potency and cytotoxicity of Kojic acid in selected skin cancer cell
lines.
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4. PLAN OF WORK
Collection of fungal strain (Aspergillus niger MTTC2208)
↓
Nutritional [carbon/nitrogen] optimization in media
↓
Fermentation of Kojic acid [submerged]
↓
Isolation of biosynthesized Kojic acid
↓
Confirmation and Quantification of biosynthesized Kojic acid
↓
Antimicrobial & Cytotoxic evaluation
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5. MATERIALS AND METHODS
Table 2 : Materials
S. No Chemicals/Culture/Instruments Company
1. Potato  Dextrose  Agar Hi-Media
2. Muller  Hinton  Agar Hi-Media
3. Glucose Nice chemicals
4. Sucrose Nice chemicals
5. Peptone Hi-Media
6. Ammonium Sulphate Qualigens
7. Sodium  nitrate Nice chemicals
8. Potassium di hydrogen phosphate Finar chemicals
9. Magnesium Sulphate Fischer
10. Potassium chloride Qualigens
11. Ferrus sulphate Nice chemicals
12. Ethyl acetate Nice chemicals
13. Ferric chloride Nice chemicals
14. Standard antibiotic discs Hi-Media
15. Ethanol Otto
16. Aspergillus  niger MTCC  2208 IMTECH, Chandigar
17. C.Albicans IMTECH, Chandigar
18. Escherichia  coli Bose  lab,  Madurai
19. Pseudomonas aeruginosa Bose  lab,  Madurai
20. Bacillus subtilus Bose  lab,  Madurai
21. Staphylococcus  aureus Bose  lab,  Madurai
22. Rotary vacuum evaporator Roteva
23. Incubator ILTC
24. Autoclave Equitron
25. pH Meter Systronics
6. METHODOLOGY
6.1  CULTURE
The selected fungal strain for the current  study is  Aspergillus niger  MTCC
2208  and was procured from IMTECH, Chandigarh and maintained in CYA slants as
per IMTECH guidelines.
6.2  CULTURE MAINTENANCE
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                          Table 3:  Composition of Czapek concentrate
S. No. INGREDIENTS QUANTITY
1.
2.
3.
4.
5.
6.
Sodium nitrate
Potassium chloride
Magnesium sulphate
Ferrus silphate
Distilled water
Ph
30.0  g
5.0    g
5.0    g
0.1    g
100.0ml
7.2
        Table 4:  Composition of Czapek yeast agar medium
S. No. INGREDIENTS QUANTITY
1.
2.
3.
4.
5.
6.
Czepak concentrate
Di potassium hydrogenphosphate
Powdered yeast extract
Sucrose
Agar
Distelled water
10.0 g
1.0   g
5.0   g
30.0 g
15.0 g
1.0   L
Czapek  yeast  agar  medium  was  prepared  and  sterilized  by  autoclaving  at
121 o C  for 15 minutes. The organism was streaked on the surface on the surface of
CYA as per IMTECH,Chandigarh standard procedure, the plates were incubated at
25± 2 o C  for 24 hour. Further subculture was done in potato dextrose broth medium
(pH 5.1). The seed culture for our expremental studies was done in PDB medium and
the culture grown in was streaked in experimental media.
6.3  NUTRITIONAL [CARBON/NITROGEN] OPTIMIZATION IN MEDIA
Since carbon and nitrogen has significant role in biosynthesis of extracellular
Kojic acid,sucrose,  glucose,  peptone [N2  (O) ] and ammonium sulphate [N2  (IO) ]
were added in varied concentration to the Czapek- Dox medium [CD] which is a basic
media recommended for Kojic acid biosynthesis in most of the protocols described
earlier.
Table 5:  Concentration of carbon and nitrogen utilized
S.No
Carbon
source
Concentration
g/l
Nitrogen sources
Concentration
g/l
1. Glucose 35 , 45 , 55 Peptone 5, 10 , 15
2. Sucrose 35, 45 , 55
Ammonium
sulphate
5, 10 , 15
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6.4  FERMENTATION OF KOJIC ACID (SUBMERGED)
Fermentation  for  biosynthesising  Kojic  acid  was  done  using  submerged
fermentation.  Various  runs  were  employed  as  described  in  table  6.  Periodicaly
subcultured 5ml of A.niger MTCC 2208 (inoculum) was added in sterilized modified
czapek  dox media  previously loaded  with carbon  and nitrogen  sources.The entire
flask were incubated for 14 days at  25 ± 2o C.  
                                Table 6:  Scheme For Fermentation
S.
No.
DESCRIPTION          RUNS
1. Czapek- Dox  (CD) 1
2. Glucose + CD 3
3. Sucrose  + CD 3
4. N2  (O)   + CD 3
5. N2  (IO)  + CD      3
6. Glucose +N2(O) + CD                           9
7. Glucose+N2 (IO)+CD 9
8. Sucrose+N2 (O)+CD           9
9. Sucrose+N2 (IO)+CD             9
10.  Total      49
6.5 ISOLATION OF KOJIC ACID
The mycelia obtained by the above runs were seprated by filteration through
whattman filter paper no.1 filter paper. Equal volume of ethyl acetate was added to all
flasks  containing  fermented  broth.  Then,  the  mixture  was  shaken  in  a  separating
funnel over night. The organic layers were seprated and collectd. The solvent was
removed in vaccum using a rotarory vaccum evaporator. The residue was collected
and  weighed.  The  weight  of  resides  were  tabulated  in  table  7  and  8.  Kojic  acid
obtained from all the 49 runs were pooled together and subjected to antimicrobial and
cytotoxic evaluation.
6.6 QUANTIFICATION OF KOJIC ACID 
Kojic acid produced in fermentation was estimated by reacting the properly
diluted samples with 1% ferric chloride in 0.1 N Hcl. The absorbance at 505 nm was
read and interpreted with Kojic acid standard curve the volumes were represented in
table 7 and 8.
6.6.1 Standard curve 
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Kojic acid 10mg  was dissolved in 10ml CD, 1ml of ferric chloride and 0.1N
hydrochloric acid were added to the above solution, 100µ, 200µ, 400µ, 800µ, 1600µ,
3200µ,  were  taken  and  the  absorbance  was  read  at  505  nm.  Graph  was  ploted
concentration with absorbance shown in table 9 and graph 4.
6.7 ANTIMICROBIAL ACTIVITY – DISC DIFFUSION METHOD
Of the many media available, MHA and PDA were considered to be best for
routine susceptibility testing of bacteria and antifungal for the following reasons :
• It shows acceptable batch to batch reproducibility for susceptibility testing.
• It gives satisfactory growth of most pathogens. 
MHA and PDAwere  prepared from available  dehydrated base  according to
manufacturers instructions. Immediatelly after autoclaving , it allowed to cool in a
45-50 oC water bath. The freshely prepared and  cooled medium was poured inti glass
petridishes on alevel,  horizontal   surface to give auniform depth of approximetaly
4mm. The agar medium was allowed to cool to room temperature.  Representative
sample of each batch of plates was examined for sterility by incubating at 30 to 35 o C
for 24 hours or longer.
 Whatman filter paper no.1 is used to prepare approximately 8mm in diameter,
which  was placed in petridish and sterilized  in ahot air oven. These sterilized discs
were then loaded with the component (Kojic acid)  dissolved in methanol with the
required concentration using micropipette and it was dried.
Penicilln G (10µg) was used as standard disc for bacteria.
Fluconazole (10µg) was used as standard disc for fungi
Methanol was  used as a control.
The prepared disc were stored in air closed tight container in refrigerator  until
use.  Inoculation of  test  plates.  A sterile  cotton swap was dipped  into the culture
( Escherichia.coli, Staphylococcus aureus, Bacillus subtilus,P vulgaris, pseudomonas
aeurgenosa, A.niger, C.albicans..).
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The swab were rotated several times and pressed firmly  on the inside wall of
the  tube this will  remove excess inoculums from the swab.  The dried surface of
Muller-Hinton agar plate was inoculated by streaking the swab over the sterile entire
agar surface. This procedure is repeated by streaking two more times, rotating the
plate 60 0 each time to ensure an even distribution of  inoculums. The lid may left after
for 3-5 min, but no more than 15 min, to allow for any excess moisture to be absorbed
before applying the drug  impregenated  discs. The disc is dispenced into inoculated
agar  plate using sterile  forceps .  Each disc was pressed down to ensure complete
contact with the agar surface. The disc was distributed evenly so that they will not
closer to each other. The plates were  inverted and  placed in an incubator set to 35 o C
with in 15 minutes after the discs  were  applied. After 18 hours of incubation the
plate was examined . The resulting zones of inhibition will be uniformally circular
and there was a confluent lawn of growth. The diameter of the zones of complete
inhibitions  were  measured.  The  zone  were  measured  using  a  measure  scale  and
tabulated in table 10.
6.8 CYTOTOXIC ACTIVITY 
 In vitro cytotoxicity of Kojic acid
Chemicals
3-(4,5–dimethyl thiazol–2–yl)–5–diphenyl tetrazolium bromide (MTT), Fetal
Bovine serum (FBS), Phosphate Buffered Saline (PBS), Dulbecco’s Modified Eagle’s
Medium (DMEM) and Trypsin were obtained from Sigma Aldrich Co, St Louis, USA.
EDTA, Glucose and antibiotics from Hi-Media Laboratories Ltd., Mumbai. Dimethyl
Sulfoxide (DMSO) and Propanol from E.Merck Ltd., Mumbai, India.
Cell lines and Culture medium
3T3L1 cell line was procured from National Centre for Cell Sciences (NCCS),
Pune, India. Stock cells were cultured in DMEM supplemented with 10% inactivated
Fetal  Bovine  Serum  (FBS),  penicillin  (100  IU/ml),  streptomycin  (100  g/ml)  and
amphotericin B (5  µg/ml) in an humidified atmosphere of 5% CO2 at  37µC until
confluent.  The  cells  were  dissociated  with  TPVG  solution  (0.2%  trypsin,  0.02%
EDTA, 0.05% glucose in PBS). The stock cultures were grown in 25 cm2 culture
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flasks and all experiments were carried out in 96 microtitre plates (Tarsons India Pvt.
Ltd., Kolkata, India). 
Preparation of Test Solutions
For cytotoxicity studies, weighed test drug was separately dissolved in DMEM
supplemented  with  2%  inactivated  FBS  to  obtain  a  stock  solution  of  1  mg/ml
concentration and sterilized by filtration. Serial two fold dilutions were prepared from
this for carrying out cytotoxic studies.
Determination of cell viability by MTT Assay
The ability of the cells to survive a toxic insult has been the basis of most
cytotoxicity assays.  This assay is based on the assumption that  dead cells or their
products do not reduce tetrazolium. The assay depends both on the number of cells
present  and  on  the  mitochondrial  activity  per  cell.  The  principle  involved  is  the
cleavage of tetrazolium salt 3-(4, 5 dimethyl thiazole-2-yl)-2, 5-diphenyl tetrazolium
bromide (MTT) into a blue coloured product (formazan) by mitochondrial enzyme
succinate dehydrogenase. The number of cells was found to be proportional to the
extent of formazan production by the cells used (Francis and Rita, 1986).
The monolayer cell culture was trypsinized and the cell count was adjusted to
1.0 x 105  cells/ml using DMEM containing 10% FBS. To each well of the 96 well
microtitre plate, 0.1 ml of the diluted cell suspension (approximately 10,000 cells)
was added. After 24 h, when a partial monolayer was formed, the supernatant was
flicked off,  washed the monolayer  once with medium and 100  °l  of  different  test
concentrations  of  test  drugs  were  added  on to  the partial  monolayer  in  microtitre
plates. The plates were then incubated at 37o C for 3 days in 5% CO2 atmosphere, and
microscopic examination was carried out  and observations were noted every 24 h
interval. After 72 h, the drug solutions in the wells were discarded and 50 µl of MTT
in PBS was added to each well. The plates were gently shaken and incubated for 3 h
at 37o C in 5% CO2 atmosphere. The supernatant was removed and 100 µl of propanol
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was added and the plates were gently shaken to solubilize the formed formazan. The
absorbance was measured using a microplate reader at a wavelength of 540 nm. The
percentage  growth  inhibition  was  calculated  using  the  following  formula  and
concentration of test drug needed to inhibit cell growth by 50% (CTC50) values is
generated from the dose-response curves for each cell line.
                 Mean OD of individual test group          
   % Growth Inhibition =     100(                                                            ) X 100
                Mean OD of control group
6.9 Spectral  analysis
FT-IR spectrum of  Kojic acid 
Spectral analysis was carried out to determine the Kojic acid extracted from 
Aspergillus niger MTCC 2208 broth. The IR spectrum of standard Kojic acid and 
sample obtained after fermentation were compared and shown in figure 2,3 and 
interpreting the frequency on table 12.
7. RESULT AND DISCUSSION
7.1  PRELIMINARY RESULTS
Aspergillus  niger  MTCC  2208  organism  was  procured  from  IMTECH
Chandigarh. The organism was subcultured in modified Czapek Dox medium. The
modified Czepak broth medium was prepared using different  carbon and nitrogen
sources  with  different  concentration  explained  in  table  5.  The  organism  was
inoculated and incubated at  25 ± 2o C  for 14 days.
7.1.1 Crude extraction
Isolation of Kojic acid was done by filtering the biomass using Whatman filter
paper no 1 and the supernatant was extracted with equal amount of organic solvent
ethyl acetate, the solution was kept in shaker for overnight, two layer were formed,
the organic layer was separated by separating funnel and evaporated by rotary vacuum
evaporator .The biomass was dried and weighed by dry weight method.
7.1.2 Nutritional [Carbon/Nitrogen] Optimization in Media
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The choice of carbon and nitrogen sources for the fermentation medium can be
an important factor influencing the subsequent fermentation (Futamura et al 2001). In
most fermentation processes, the concentration of the nitrogen and/or carbon source in
the medium is  increased  to  secure high  productivity,  there for,  when selecting an
optimum production medium, it is very important to select a medium yielding low cell
concentration (Ariff et al 1996). From the above study the highest yield of kojic acid
was obtained in the fermentation using glucose as a carbon source and peptone as an
organic  a  nitrogen  source  when compared with sucrose  and  peptone.  The highest
production of  kojic  acid was  obtained at  concentration of  55g glucose and 5g of
peptone as a nitrogen source and the yield was 1144.7µg, so the production of kojic
acid increased with the increase of carbon source and decrease of nitrogen source, the
weight of the biomass dose not have any effect on the quantity of kojic acid produced.
The concentrations of kojic acid produced by different concentrations of carbon and
nitrogen sources were shown in table 8.
7.1.2.1 Effect of carbon source in biosynthesizing Kojic acid
In  this  study  glucose  and  sucrose  are  the  two  carbon  sources  utilized  for  the
biosynthesis of kojic acid at varied concentrations of 35, 45, and 55 g/l. the highest
yield  of  kojic  acid was obtained  in  the  fermentation using glucose  as  the  carbon
source followed by sucrose and fructose (Rosfarizan Mohamed et al 2010). Also some
other  study  reported  that  the  glucose  concentration  ranging  from  25-150  g/l
influenced the production of kojic acid synthesis (Kitada et al 1967). In this study
czepak dox when combined with glucose concentrations 35,45 and 55 g/l achieved
high biomass 3.6 g/l while no kojic acid was synthesized. As the same thing when
sucrose as carbon source added with czepak dox medium for fermentation maximum
biomass and no kojic acid synthesis was achieved. This shows carbon source alone is
not worthwhile for the synthesis of kojic acid production. When the carbon sources
combined with nitrogen biomass as well as kojic acid synthesis was seen.
When carbon  sources  at  45  and 55 g/l  combined  with 5-15  g/l  concentrations  of
nitrogen organic and inorganic, reported to produce high yield of biomass and kojic
acid. In  the above combinations if nitrogen source is high the effect  of kojic acid
production becomes less but biomass concentration obtained was high. This shows the
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production relies upon the concentration of carbon as well as nitrogen sources. Some
other study explains that sucrose was the best source for producing kojic acid (Wei et
al 1991), but from this study it is under stood that concentration plays a major role.
Nitrogen organic with glucose profounds yield high quantity of kojic acid compared
to nitrogen inorganic which is negligible.
7.1.2.2 Effect of nitrogen source in biosynthesizing Kojic acid
Organic nitrogen source always contains  important  growth factors  which plays  an
important  role  in  enhancing  biomass  production  (Gad  2003).  So  It  becomes
mandatory for nitrogen to be considered as a major source in growth but limited for
kojic acid synthesis as per the result obtained in this study. Hence nitrogen limited
fermentation is required for biosynthesizing kojic acid (Ariff et al 1996). In this study
peptone  and  ammonium  sulphate  were  utilized  as  nitrogen  organic  and  nitrogen
inorganic sources respectively in varied concentrations of 5, 10, and 15 g/l. nitrogen
alone in combination with czepak dox medium doesn’t produced any kojic acid and
biomass as well. When least concentration of nitrogen organic/inorganic was added
with  glucose/sucrose,  it  yield  high  quantity  of  kojic  acid  but  negligible  at  high
concentrations.  This  confirms  that  low  concentrations  are  needed  to  perform  the
biosynthesis of kojic acid.
WEIGHT OF BIOMASS AND CRUDE EXTRACT 
Table 7: Concentration (g) of carbon and nitrogen sources added to Czepak dox
media
S.
No.
Description of runs Biomass(g/l) Quantity of
Kojic acid(µg/l)
1. Czepak dox (1L) 1.3 -
2. Czepak dox +Glucose
35 3.2 -
45 3.6 -
55 3.3 -
3. Czepak dox+Sucrose
35 3.1 -
45 3.3 -
55 3.3 -
4. Czepak dox+Nirogen (O)
5 1.4 -
10 1.3 -
15 1.1 -
5. 5 1.3 -
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Czepak dox+Nitrogen (IO) 10 1.1 -
15 1.1 -
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Table 8 :  Concentration (g) of combined carbon and nitrogen sources added to 
Czepak dox media
S. 
No Description of runs
Biomass
(g/l)
Quantity of     
Kojicacid(µg/l
)
1.
Czepak dox +Glucose + 
N(O)
35
5 4.7 -
10 4.4 1136.4
15 4.1 -
45
5 4.3 -
10 4.3 1142.7
15 4.5 256.41
55
5 4.9 1144.7
10 4.8 946.7
15 4.7 946.7
2.
Czepak dox +Glucose + 
N(IO)
35
5 4.1 21.16
10 3.3 11.13
15 3.3 10.21
45
5 4.1 -
10 4.1 11.11
15 4.3 -
55
5 4.5 256.4
10 4.3 14.4
15 4.3 12.63
3. Czepak dox+Sucrose+ N(O)
35
5 3.9 -
10 3.6 -
15 3.3 -
45
5 3.9 -
10 3.2 14.73
15 3.6 -
55
5 4.6 1142.7
10 4.3 693.6
15 4.2 596.1
4. Czepak dox+Sucrose+ N(IO)
35
5 3.6 20.37
10 3.3 15.91
15 3.5 16.71
45
5 3.4 21.42-
10 3.7 -
15 3.9 -
55
5 4.3 8.92
10 4.5 8.68
15 3.9 6.56
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7.1.3 Quantification of Kojic acid
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                    Table 9:  Kojic acid quantification (Standard curve)
S. No. Volume of Kojic acid(µ) Absorbance (505nm)
1.
2.
3.
4.
5.
6.
100
200
300
400
500
600
0.13
0.18
0.25
0.34
0.37
0.43
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7.2 BIOLOGICAL ACTIVITIES OF THE ISOLATED  KOJIC ACID
 In vitro antimicrobial activity
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The biological  activity of each compound was investigated against a broad
spectrum of microorganisms for antimicrobial activity. Recently Kojic acid isolated
from Trichoderma  species  exhibits  potent  antimicrobial  activity  (Rashad  M  et  al
2011). In view of this current study is aimed at evaluating the antimicrobial efficacy
of  Kojic  acid.  The  results  (Table  no:  10)  showed  moderate  antibacterial  activity
against gram-positive bacteria  B. subtilis and S. aureus with a zone of  inhibition 10
and 11mm respectively at a concentration of  100 µg/ml  and a zone of inhibition 11
and 12mm  respectively at a concentration of  200 µg/ml . Gram-negative bacteria
was highly sensitive to kojic acid showing a zone of inhibition diameter of 10mm and
16 against  p.vulgaris  and P. aeruginosa  respectively at aconcentration of 100 µg/ml
and a zone of inhibition of  11mm and 18 mm  at a   concentration of 200 µg/ml. 
Antifungal activity of kojic acid was tested against one selected filamentous
(A.niger)  and  one  unicellular  fungi  (c.albicans)  using  Zone  of  inhibition  method.
Kojic acid affected  A. niger  with a higher  zone of inhibition 14mm and 16mm at
100µ g/ml  and  200µg/ml  concentration  respectively.  Kojic  acid  was  less  potent
against other one unicellular fungi  C. albicans  with  zone of inhibition diameter of
11mm  and  14mm  at  a  concentration  of  100µg/ml  and  200µg/ml  respectively.
fluconazole is used as a control. 
Table 10 : Susceptability analysis of bacteria and fungi
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Susceptability  analysis
Zone of inhibition (mm)
S.NO.    STRAIN KOJIC ACID STANDARD
1
STANDARD
2100µg 200µg
1.
2.
3.
4.
5.
6.
S.aureus
B.subtilus
P.vulgaris
P.aeruginosa
A.niger
C.albicans
14
10
10
16
24
13
16
11
12
18
26
16
25
14
25
23
-
-
-
-
-
-
10
36
       STANDARD 1 :  Penicillin G 10µg
       STANDARD 2 : Fluconazole  10µg
Susceptability analysis of bacteria and fungi
Zone of inhibition (mm)
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Photo: 1 Sensitivity assay
Photo: 2 Sensitivity assay
Photo: 3  Sensitivity assay
50
Photo: 4  Sensitivity assay
Photo: 5 Sensitivity assay
51
Photo: 6 Sensitivity assay
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7.3 Cytotoxicity of Kojic acid
          The preliminary objective of the study is to determine the toxicity of kojic acid.
The method chosen was MTT cell cytotoxicity assay. In this method the absorbance
of the formed formazan crystals were estimated calorimetrically by which the live
cells after the treatement with the drug can be estimated. Through this IC  50 of the
drug is calculated using slope established. Here in this study the IC 50 was found to be
513.33±5.77 µg/ml when tested against 3T3L1 skin cancer cell line (table 11 ). Many
genotoxicity analysis were performed for kojic acid and was reported to have gene
toxicity (Satomi Kawaghuchi et al 2007). Hence in this study we may able to report
this kojic  acid as  toxic substance  in higher  concentrations,  from our experimental
data.
7.3.1 CYTOTOXICITY EVALUATION
Table 11:  Cytotoxic properties of test drugs against 3T3L1 cell line.
S. No
Name of Test 
sample
Test  Concn.
( µg/ml)
% 
Cytotoxicity
CTC50  ( µg/ml)
1. Kojic acid
1000
500
250
125
62.5
91.86±0.13
49.27±0.27
40.71±0.88
37.21±1.44
29.45±0.94
513.33±5.77
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Graph 6: Graphical representation of cytotoxic effect of Kojic acid
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7.4 FT-IR spectrum of  Kojic acid 
Spectral analysis was carried out to determine the Kojic acid extracted from
Aspergillus niger  MTCC 2208 broth.  The IR spectrum of standard Kojic acid and
sample obtained after fermentation were compared. The group assigned (Table no 12)
in both the spectrum showed strong similarity by which the biosynthesized Kojic acid
is confirmed. 
Table 12: Interpretation of IR spectrum
S. 
No
.
WAVE NUMBER cm-
1
STANDARD
WAVE NUMBER cm-
1
SAMPLE
GROUP
ASSIGNMENT
1.
2.
3.
4.
5.
6.
7.
3530.8
3174
2924.19
1702.86
1579.43
1282
941
3632.2
3100
2828.09
1661.07
1611.85
1202
847
OH    STRETCHING
CH    STRETCHING
CH    STRETCHING
C=O  STRETCHING
C=C  STRETCHING
C-O   STRETCHING
C-H   DEFORMATION
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                           Figure 2:  IR spectrum of Standard Kojic acid
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                                Figure 3:  IR spectrum of Isolated Kojic acid
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8. SUMMARY AND CONCLUSION
The selected fungal strain for our study is  Aspergillus niger  MTCC 2208  and was
procured from IMTECH, Chandigarh and maintained in CYA slant, the fermentation
process (submerged) was performed by adding 5 ml of  Aspergillus niger  MTCC
2208  inoculum culture in sterile  Modified Czapek-  Dox medium and was incubated
at  25 ± 2o C  for 14  days.
Submerged  fermentation  technique  was  adapted  to  biosynthesize  Kojic  acid  from
Aspergillus  niger.  The  highest  production  of  kojic  acid  was  obtained  at  a
concentration of 55g glucose  and 5g of peptone as an organic a nitrogen source and
the yield was 1144.7µg, from this study we concluded that the production of Kojic
acid increased with the increase of carbon source such as glucose and decreased with
the decrease of organic  nitrogen source such as peptone, the Kojic acid  which was
obtained  from  the  49  runs  were  pooled  together  and  utilized  to  evaluate  its
antimicrobial and cytotoxic activity.
Kojic acid was tested against four bacterial strains and two fungal strains using Disc
diffusion method. Kojic acid showed moderate antibacterial activity when compared
with the antifungal activity which gave good potency. Kojic acid is tested against Skin
cell lines (3T3L1) and IC 50 was found to be 513.33±5.77 µg/ml.
By all  these results  we can conclude that  biosynthesize of kojic acid need excess
concentration  of  carbohydrate  source  with  decreased  amount  of  nitrogen  organic
source. Kojic acid definitely possesses antifungal activity with high potency rather
than antibacterial activity. From the cytotoxic report it can be concluded that kojic
acid upon high concentration produce toxic to the skin.
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